Skip to content

Clinical trials

Completed Leukemia, Biphenotypic, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Status: Completed Country / region: United States Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20014
20024
20035
20044
20055
20064
20077
20085
20094
20103
20114
20121
20132
20146
20154
20164
20173
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed106

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center16
National Cancer Institute (NCI)13
Memorial Sloan Kettering Cancer Center9
M.D. Anderson Cancer Center7
Children's Oncology Group6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Case Comprehensive Cancer Center4
Northwestern University4
Wake Forest University Health Sciences4
University of Washington3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute106
Precursor Cell Lymphoblastic Leukemia-Lymphoma89
Leukemia, Myeloid, Acute75
Leukemia59
Leukemia, Lymphocytic, Chronic, B-Cell58
Burkitt Lymphoma53
Lymphoma, Non-Hodgkin49
Myelodysplastic Syndromes49
Leukemia, Myelomonocytic, Chronic48
Lymphoma, Follicular48

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.